# Reciprocal Labs Corporation – FDA Inspection, Aug 2, 2023

Source: https://www.keypedia.com/records/fda_inspections/reciprocal-labs-corporation/89912806-693d-48e5-8489-aad064b045e5
Source feed: FDA_Inspections

> FDA inspection 1214786 of Reciprocal Labs Corporation, August 02, 2023. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 820. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1214786
- Company Name: Reciprocal Labs Corporation
- Inspection Date: 2023-08-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 1

## Related Documents

- FDA Inspection 1084409 - 2018-12-13

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/albert-l-nguyen/496338d0-71c4-43da-92f0-09515559d9fc)

Company: https://www.keypedia.com/companies/reciprocal-labs-corporation/e9f38def-f31d-4a47-bcd6-212ed9dcee8c

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7